Background - Diagnosing Parkinson's disease (PD) and tracking its progression may require the combination of reliable biomarkers. Among them, both serum uric acid (UA) and dopamine transporter (DaT) binding deserve more investigations. Aims of the study - We aimed to investigate the relationship between serum UA levels and DaT availability in newly diagnosed, drug-naEUR?ve PD patients, by means of semiquantitative [(123) I]FP-CIT-SPECT. Methods - We recruited 52 newly diagnosed, drug-naEUR?ve PD patients, and performed serum UA dosage and [(123) I]FP-CIT-SPECT. Results - Pearson's correlation analysis showed that UA levels were significantly higher in patients with higher averaged, ipsilateral and contralateral DaT binding in caudate, putamen, and striatum. Conclusions - We showed, for the first time, by regional semiquantitative analysis of DaT binding in PD patients that UA levels significantly correlates with the severity of dopaminergic impairment in caudate, putamen, and striatum. This study broadens our knowledge on the importance of UA as a biomarker of PD.

Uric acid relates to dopamine transporter availability in Parkinson's disease

S Pappata;
2015

Abstract

Background - Diagnosing Parkinson's disease (PD) and tracking its progression may require the combination of reliable biomarkers. Among them, both serum uric acid (UA) and dopamine transporter (DaT) binding deserve more investigations. Aims of the study - We aimed to investigate the relationship between serum UA levels and DaT availability in newly diagnosed, drug-naEUR?ve PD patients, by means of semiquantitative [(123) I]FP-CIT-SPECT. Methods - We recruited 52 newly diagnosed, drug-naEUR?ve PD patients, and performed serum UA dosage and [(123) I]FP-CIT-SPECT. Results - Pearson's correlation analysis showed that UA levels were significantly higher in patients with higher averaged, ipsilateral and contralateral DaT binding in caudate, putamen, and striatum. Conclusions - We showed, for the first time, by regional semiquantitative analysis of DaT binding in PD patients that UA levels significantly correlates with the severity of dopaminergic impairment in caudate, putamen, and striatum. This study broadens our knowledge on the importance of UA as a biomarker of PD.
2015
biomarkers
dopamine transporter
Parkinson's disease
SPECT
urate
uric acid
uric
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/299883
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 31
social impact